Seniors With Insomnia More Vulnerable to Inflammatory Challenge-Induced Depression
By Elana Gotkine HealthDay Reporter
MONDAY, July 21, 2025 -- Older adults with insomnia are more vulnerable to depressive mood and symptoms in response to inflammatory exposure, according to a study published online July 16 in JAMA Psychiatry.
Michael R. Irwin, M.D., from the Jane and Terry Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, and colleagues examined whether inflammatory exposure induces greater increases in depressive mood and symptoms in older adults with insomnia disorder versus those without insomnia in a parallel-condition randomized clinical trial. The trial included 160 nondepressed adults aged 60 years or older (53 with insomnia disorder and 107 without insomnia). Participant groups were randomly assigned to two conditions: endotoxin (79 participants: 26 with insomnia and 53 controls) or placebo (81 participants: 27 with insomnia and 54 controls).
The researchers found that endotoxin induced increases in Profiles of Mood States depression subscale (POMS-D) to a significantly greater extent compared with placebo in those with insomnia versus control, with a similar effect seen for observer-rated POMS-D mood. In addition, there were clinically meaningful increases seen in observer-rated measures of depressive symptoms. In both groups, similar increases in inflammatory cytokines were induced by endotoxin. In moderation analyses, inflammatory response was associated with increases in POMS-D in the insomnia group but not the control group.
"Insomnia not only robs older adults of rest but also primes their immune system to make them uniquely vulnerable to depression when faced with inflammation," Irwin said in a statement. "Treatments targeted at this inflammation-related depression may prevent depression and benefit these patients to improve their overall quality of life."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Self-Medication With Cannabis Linked to Anxiety, Depression, Paranoia
THURSDAY, Sept. 4, 2025 -- Initiating cannabis use for self-medication is associated with higher weekly use and increased anxiety, depression, and paranoia, according to a study...
Suicide Deaths by Firearms Increasing Among Older Women
THURSDAY, Sept. 4, 2025 -- Suicide deaths by firearms have increased among older women, according to a research letter published online Aug. 26 in JAMA Network Open. Ziming Xuan...
Cannabis-Based Medical Products Aid Primary Insomnia
TUESDAY, Sept. 2, 2025 -- Insomnia patients taking cannabis-based medicinal products report better quality sleep, according to a study published online Aug. 27 in PLOS Mental...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.